394 Volumetric Analysis of Changes in Tumor Burden Following MR-Guided Low Intensity Focused Ultrasound With Aminolevulinic Acid Sonodynamic Therapy (ALA SDT) in Patients With Diffuse Intrinsic Pontine Glioma

View at publisher Summarise with VIRAT
Authors: Joseph H. McAbee, John S. Myseros, Chima O. Oluigbo, Robert F. Keating, Hasan R. Syed
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: ALA SDT leverages low-intensity focused ultrasound (LIFU) to activate protoporphyrin IX, a metabolite of 5-ALA which selectively accumulates in tumor cells. PPIX generates reactive oxygen species that initiate tumor cell apoptosis. This novel approach offers a non-invasive, targeted cytotoxic modality. ALA SDT has been shown to slow glioma growth and extend survival in animal models once activated by focused ultrasound. METHODS: The initial diagnosis, pre-SDT, and post-SDT MRI Brain scans of the first cohort of three pediatric DIPG patients who underwent MRgLIFU treatment at Children’s National Hospital were studied. Brainlab imaging software was utilized to perform 3D volumetric analysis of tumor volumes. Additionally, extent of tumor-associated edema, progression-free survival, and overall survival were determined. RESULTS: Two of the three patients experienced a decrease in tumor volume after SDT with MRgLIFU, with the largest change in volume being a decrease from 25.9 cm3 to 11.4 cm3. The third patient experienced transient volume decreases and overall tumor stability throughout many months of treatment, but was found to have slight progression after the 9th round of SDT. Similarly, tumor-associated edema was stable to slightly improved across all patients after treatment. Progression free survival ranged from 263-694 days, while overall survival ranged from 288-1012 days, with one patient still being alive at last follow-up. CONCLUSIONS: From our initial cohort, ALA SDT appears to induce early, measurable changes in tumor imaging characteristics, including volumetric analysis. These findings support the potential for SDT as a safe, non-invasive therapeutic strategy in patients with DIPG. Continued radiographic analysis will provide further information on tumor changes following treatment.

Fields of Study & Subjects

Ultrasound and Hyperthermia Applications Glioma Diagnosis and Treatment Photodynamic Therapy Research Studies

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
109–110
Publication date
26 March 2026
Language
EN